The invention provides a combination of a) a compound ofFormula Ia: [insert Formula Ia.], or a pharmaceutically acceptable saltthereof,and b) vemurafenib or a pharmaceutically acceptable salt thereof for theprophylactic or therapeutic treatment of a hyperproliferative disorder, suchas cancer.